---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-025951"
form_type: "8-K"
ticker: "IRON"
cik: "0001816736"
company_name: "Disc Medicine, Inc."
filed_at: "2024-02-07T23:59:59+00:00"
generated_at: "2026-06-06T07:13:48.130068+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Disc Medicine appoints Jean Franchi as CFO effective Feb 7, 2024; promotes Jonathan Yu to COO

## Summary
- Jean Franchi appointed CFO, replacing Joanne Bryce who transitions to consulting; effective Feb 7, 2024.
- Franchi receives $515k base salary, $75k signing bonus, 40% target bonus; inducement equity: option for 55k shares and RSU for 36,666 shares.
- Franchi brings 30+ years experience; previously CFO at Replimune, Merrimack, Dimension Therapeutics, and Genzyme.
- Jonathan Yu promoted from Chief Business Officer to COO effective Feb 7, 2024.
- Equity inducement awards granted outside the 2021 stock plan per Nasdaq Listing Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001193125-24-025951
- form_type: 8-K
- ticker: IRON
- cik: 0001816736
- company_name: Disc Medicine, Inc.
- filed_at: 2024-02-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/d758257d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-025951
- JSON: https://secwatch.observer/filing/0001193125-24-025951.json
- Plain text: https://secwatch.observer/filing/0001193125-24-025951.txt

## Key facts
- Executive change
  Jonathan Yu changed role as Chief Operating Officer at Disc Medicine, Inc..
  - Action: promoted
  - Role: Chief Operating Officer
  source text: On February 7, 2024 (the "Promotion Date"), the Company announced that Jonathan Yu, the Company's previous Chief Business Officer, was promoted to serve as the Company's Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm
- Executive change
  Jean M. Franchi was appointed as Chief Financial Officer and Treasurer at Disc Medicine, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Treasurer
  source text: On February 7, 2024, the Company announced the appointment of Jean M. Franchi as Chief Financial Officer and Treasurer, effective February 7, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm
- Executive change
  Joanne Bryce departed as Chief Financial Officer and Treasurer at Disc Medicine, Inc..
  - Action: departed
  - Role: Chief Financial Officer and Treasurer
  source text: Ms. Franchi succeeds Joanne Bryce, who, as previously announced by the Company, will depart from her role as Chief Financial Officer and Treasurer, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816736/000119312524025951/0001193125-24-025951-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.